Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Trends in Pharmacological Sciences|August 1, 1992
Designing therapeutically effective 5-lipoxygenase inhibitorsR M McMillan, E R Walker
Toxicology|January 1, 1982
Neonatal toxicity in rats following in utero exposure to chlorphentermine or phentermineD Thoma-Laurie, E R Walker, M J Reasor
Research Communications in Chemical Pathology and Pharmacology|November 1, 1982
Chlorcyclizine--induced pulmonary phospholipidosis in ratsM J Reasor, C A Heyneman, E R Walker
Experimental and Molecular Pathology|June 1, 1983
Chlorphentermine-induced neonatal and maternal pulmonary phospholipidosis in ratsD L Thoma-Laurie, E R Walker, M J Reasor
Clinical Nutrition (Edinburgh, Scotland)|April 1, 1992
A patient with jejunostomy liberated from home intravenous therapy after 14 years; contribution of balance studiesJ M Nightingale, J E Lennard-Jones, E R Walker
The American Review of Respiratory Disease|March 1, 1988
Amiodarone-induced phospholipidosis in rat alveolar macrophagesM J Reasor, C L Ogle, E R Walker, et al.
Journal of Immunopharmacology|January 1, 1986
Morphological and functional changes in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermineL J Sauers, D Wierda, E R Walker, et al.
British Journal of Pharmacology|January 1, 1990
2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activityS J Foster, P Bruneau, E R Walker, et al.
Pageof 4